Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bialer

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 1999
Pharmacokinetic considerations in the design of better and safer new antiepileptic drugsM Bialer
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1980
A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processesM Bialer
Biopharmaceutics & Drug Disposition|October 1, 1981
An alternative method for calculating simple pharmacokinetic parameters for zero-order absorption and first-order elimination processesM Bialer
Clinical Pharmacokinetics|June 1, 1993
Comparative pharmacokinetics of the newer antiepileptic drugsM Bialer
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 28, 2005
[Interactions of antiepileptic drugs]M Bialer
Clinical Pharmacokinetics|February 1, 1991
Clinical pharmacology of valpromideM Bialer
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implicationsM Bialer
Biopharmaceutics & Drug Disposition|October 23, 1997
Pharmacokinetic analysis and antiepileptic activity of two new isomers of N-valproyl glycinamideS Hadad, M Bialer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1988
Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogsE Samara, M Bialer
Biopharmaceutics & Drug Disposition|March 23, 1999
Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equationA Volosov, M Bialer
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 1999
Pharmacokinetic considerations in the design of better and safer new antiepileptic drugsM Bialer
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1980
A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processesM Bialer
Biopharmaceutics & Drug Disposition|October 1, 1981
An alternative method for calculating simple pharmacokinetic parameters for zero-order absorption and first-order elimination processesM Bialer
Clinical Pharmacokinetics|June 1, 1993
Comparative pharmacokinetics of the newer antiepileptic drugsM Bialer
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 28, 2005
[Interactions of antiepileptic drugs]M Bialer
Clinical Pharmacokinetics|February 1, 1991
Clinical pharmacology of valpromideM Bialer
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implicationsM Bialer
Biopharmaceutics & Drug Disposition|October 23, 1997
Pharmacokinetic analysis and antiepileptic activity of two new isomers of N-valproyl glycinamideS Hadad, M Bialer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1988
Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogsE Samara, M Bialer
Biopharmaceutics & Drug Disposition|March 23, 1999
Use of mean residence time to determine the magnitude of difference between rate constants and to calculate tmax in the Bateman equationA Volosov, M Bialer
Pageof 14